Reynders McVeigh Capital Management’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-9,000
Closed -$247K 208
2017
Q4
$247K Hold
9,000
0.03% 186
2017
Q3
$202K Hold
9,000
0.03% 210
2017
Q2
$238K Hold
9,000
0.03% 198
2017
Q1
$246K Hold
9,000
0.03% 198
2016
Q4
$222K Hold
9,000
0.03% 214
2016
Q3
$204K Buy
+9,000
New +$197K 0.03% 209
2016
Q2
Sell
-14,000
Closed -$366K 226
2016
Q1
$366K Hold
14,000
0.05% 164
2015
Q4
$361K Sell
14,000
-1,000
-7% -$27K 0.06% 147
2015
Q3
$337K Hold
15,000
0.06% 157
2015
Q2
$449K Buy
+15,000
New +$423K 0.07% 135

Other funds holding TBI

Reynders McVeigh Capital Management's TBI Position: Q1 2018 in Review

Reynders McVeigh Capital Management sold out of Trueblue (TBI) in Q1 2018, closing a stake of 9,000 shares — an estimated $247K sold.

Reynders McVeigh Capital Management first reported a position in TBI in Q2 2015 and held it in 10 quarters. The position peaked at $449K in Q2 2015. 196 funds tracked by Wall St. Rank hold TBI as of Q1 2018.

  • Reynders McVeigh Capital Management reported no remaining Trueblue position as of Q1 2018 after selling out during the quarter.
  • Reynders McVeigh Capital Management sold 9,000 Trueblue shares in Q1 2018, an estimated $247K.
  • Reynders McVeigh Capital Management first reported a position in Trueblue in Q2 2015 and held it in 10 quarters.
  • Reynders McVeigh Capital Management's Trueblue position peaked at $449K in Q2 2015.
  • 196 funds tracked by Wall St. Rank held Trueblue as of Q1 2018.

Based on Reynders McVeigh Capital Management's 13F filing for Q1 2018, filed 3 May 2018.